World Health Organization
The 2016 World Health Organization (WHO) Global guidelines for the prevention of surgical site infection (SSI) are evidence-based and unique in that they are the first global guidelines of this sort, are based on systematic reviews and present additional information in support of actions to improve practice. They were developed by international experts adhering to WHO’s Guideline Development Process and overall aim to achieve standardization.
AORN
The AORN Comprehensive Surgical Checklist can be downloaded and customized to meet a facility’s needs. The checklist includes key safety checks as outlined in the World Health Organization (WHO) Surgical Safety Checklist and The Joint Commission Universal Protocol. It is designed for use in all types of facilities (hospital ORs, ambulatory surgery settings, physician offices).
PubMed (nih.gov)
In colorectal surgery, the composition of the most effective bundle for prevention of surgical site infections (SSI) remains uncertain. We performed a meta-analysis to identify bundle interventions most associated with SSI reduction.
Pubmed Article
Infections at the surgical site continue to occur in as many as 20% of elective colon resection cases. Methods to reduce these infections are inconsistently applied. Surgical site infection (SSI) is the result of multiple interactive variables including the inoculum of bacteria that contaminate the site, the virulence of the contaminating microbes, and the local environment at the surgical site. These variables that promote infection are potentially offset by the effectiveness of the host defense. Reduction in the inoculum of bacteria is achieved by appropriate surgical site preparation, systemic preventive antibiotics, and use of mechanical bowel preparation in conjunction with the oral antibiotic bowel preparation. Intraoperative reduction of hematoma, necrotic tissue, foreign bodies, and tissue dead space will reduce infections. Enhancement of the host may be achieved by perioperative supplemental oxygenation, maintenance of normothermia, and glycemic control. These methods require additional research to identify optimum application. Uniform application of currently understood methods and continued research into new methods to reduce microbial contamination and enhancement of host responsiveness can lead to better outcomes.
Prepared by IPRO NQIIC
A pocket guide for clinicians to select the most recent recommendation for duration of therapy.
Easy-print foldable version available here: https://drive.google.com/file/d/1FPff30i34n3dS3XptKJC23SmMEjapZFv/view?usp=sharing
Prepared by IPRO NQIIC
This resource summarizes the dosing/coverage for two formulations of nitrofurantoin to ensure that the correct product is selected by the the clinician.
Prepared by IPRO NQIIC
Conversation Starter to assist clinicians in counseling patients on the use of opioid medication prior to discharge, in the ER or in the clinic setting.
Prepared by IPRO QIN/QIO
Video interview with a nurse describing her own C. difficile survival story. The story includes a first-person accounting of her yearlong hospitalization, the impact of antibiotic therapy, prevention of C. difficile and the long-term effects of this devastating antibiotic adverse event.
Prepared by IPRO QIN-QIO, Centers for Medicare & Medicaid Services Quality Improvement & Innovation Group
Use with Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain document and the Opioid and Pain Management Best Practice Aggregate Results Dashboard.
In this pre-recorded event, the AIR team hosts a discussion about the different stages of a PFAC, including how to identify them and how to move forward. The event features real-world examples of how hospitals have responded to the evolving needs of their PFACs. It includes a facilitated discussion about steps that all hospitals can take today to make the most of their PFACs and sustain engagement over time.
Prepared by the Agency for Healthcare Research and Quality (AHRQ)
This toolkit will provide hospital infection prevention programs with instructions for implementing targeted decolonization in adult patients with medical devices in hospital units outside of intensive care (i.e., non-ICUs).
Adapted from HSAG by IPRO QIN-QIO Network of Quality Improvement and Innovation Contractors (NQIIC), Centers for Medicare & Medicaid Services Quality Improvement and Innovation Group
This document provides a step-by-step roadmap for organizational commitment to health equity.
